Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 51   

Articles published

GSK 1,449.71 +5.21 (0.36%)
price chart
Glaxo to Begin Hostile Offer for Human Genome Sciences
Glaxo's bid is part of a wave of takeover activity in the pharmaceutical industry as drugmakers seek new products. Roche Holding AG made a hostile offer for Illumina Inc. in January, and abandoned it last month.
Glaxo's Stiefel Unit Loses $1.5 Million Verdict on Buybacks
Stiefel Laboratories lost a $1.5 million jury verdict to a former employee who claimed the company bought back his stock at artificially low prices before its acquisition in 2009 by GlaxoSmithKline Plc. Timothy Finnerty won the judgment on May 16 in ...
Google's Brin Makes Strides in Hunt for Parkinson's Cure
The advances are encouraging Pfizer Inc. and GlaxoSmithKline Plc to pursue a new class of medicines that may become the first to slow the progress of Parkinson's disease in a unique collaboration that Brin is funding.
Expand your mindfulness
Andy Parsons is a pharmacologist and neuroscientist and a vice-president at GlaxoSmithKline. An internal coach at GSK, he says that for him mindfulness is about 'being completely present and listening to what's going on around you. Being truly present ...
Gates Foundation Veteran Yamada Retools Drugmaker Takeda
Tadataka “Tachi” Yamada led global health programs for Bill and Melinda Gates, oversaw GlaxoSmithKline Plc's research, was head physician at the University of Michigan and wrote gastroenterology textbooks.
Stopping Fake Drugs From Pakistan Is Too Late for Victims
More than 2,500 stalls wedged along dirt lanes in Karachi's busiest trading district offer everything from Pfizer Inc.'s cholesterol pill Lipitor to GlaxoSmithKline Plc's painkiller Panadol. Closer study of the remedies lining rickety shelves reveals ...
Billions of dollars in taxes hang in balance at top court
A nearly 20-year battle between global drug giant GlaxoSmithKline Inc. and the Canada Revenue Agency, now being weighed by the Supreme Court of Canada, could end up rewriting the rules that allow multinationals to shift some of their profits out of ...
Where can investors find shelter from the volatility storm?
British investors should be braced for another disappointing summer, experts have warned, as a combination of poor economic growth at home and renewed concerns about the financial stability of the eurozone threatens to blow their investments off course ...
Glaxo Scientist, Surgeon Targeting Historic British Hockey Gold
MacLeod, 27, also worked for GlaxoSmithKline Plc, the U.K.'s biggest drugmaker, as a sports scientist on its Lucozade energy drink.
Prepared for the Grexit?
Despite the doom and gloom surrounding the future of Greece and the eurozone, UK plc looks like it could be in for a rude awakening.